PubMed:15820770 / 1098-1234 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T13","span":{"begin":0,"end":136},"obj":"Sentence"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}

{"project":"LitCoin-entities","denotations":[{"id":"1766","span":{"begin":75,"end":83},"obj":"DiseaseOrPhenotypicFeature"},{"id":"1767","span":{"begin":109,"end":113},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A20","pred":"db_id","subj":"1766","obj":"MESH:D003920"},{"id":"A21","pred":"db_id","subj":"1767","obj":"NCBIGene:5798"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T20","span":{"begin":4,"end":15},"obj":"GeneOrGeneProduct"},{"id":"T21","span":{"begin":27,"end":30},"obj":"GeneOrGeneProduct"},{"id":"T22","span":{"begin":35,"end":38},"obj":"GeneOrGeneProduct"},{"id":"T23","span":{"begin":39,"end":42},"obj":"GeneOrGeneProduct"},{"id":"T24","span":{"begin":75,"end":83},"obj":"GeneOrGeneProduct"},{"id":"T25","span":{"begin":109,"end":113},"obj":"GeneOrGeneProduct"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T13","span":{"begin":109,"end":113},"obj":"GeneOrGeneProduct"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T4","span":{"begin":75,"end":83},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"originalLabel","subj":"T4","obj":"DISEASE"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T4","span":{"begin":109,"end":113},"obj":"GeneOrGeneProduct"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T4","span":{"begin":75,"end":83},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"DISEASE"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T4","span":{"begin":75,"end":83},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"#label","subj":"T4","obj":"DISEASE"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T30","span":{"begin":23,"end":30},"obj":"ChemicalEntity"},{"id":"T31","span":{"begin":35,"end":38},"obj":"ChemicalEntity"},{"id":"T34","span":{"begin":39,"end":42},"obj":"ChemicalEntity"}],"attributes":[{"id":"A30","pred":"ID:","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_73828"},{"id":"A31","pred":"ID:","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_29972"},{"id":"A32","pred":"ID:","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_18237"},{"id":"A33","pred":"ID:","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_16015"},{"id":"A34","pred":"ID:","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_29972"},{"id":"A35","pred":"ID:","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_18237"},{"id":"A36","pred":"ID:","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_16015"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T34","span":{"begin":39,"end":42},"obj":"ChemicalEntity"},{"id":"T31","span":{"begin":35,"end":38},"obj":"ChemicalEntity"},{"id":"T30","span":{"begin":23,"end":30},"obj":"ChemicalEntity"},{"id":"T4","span":{"begin":109,"end":113},"obj":"GeneOrGeneProduct"},{"id":"T54075","span":{"begin":75,"end":83},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A36","pred":"ID:","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_16015"},{"id":"A35","pred":"ID:","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_18237"},{"id":"A34","pred":"ID:","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_29972"},{"id":"A33","pred":"ID:","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_16015"},{"id":"A32","pred":"ID:","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_18237"},{"id":"A31","pred":"ID:","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_29972"},{"id":"A30","pred":"ID:","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_73828"},{"id":"A52695","pred":"#label","subj":"T54075","obj":"DISEASE"}],"text":"The frequencies of the Asp/Glu and Glu/Glu were significantly increased in diabetic subjects with detectable IA-2 antibodies (P \u003c 0.01)."}